|
Volumn 349, Issue , 2014, Pages g6605-
|
Kentucky seeks $1bn from Purdue Pharma for misrepresenting addictive potential of oxycodone
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NARCOTIC AGENT;
OXYCODONE;
DRUG INDUSTRY;
HUMAN;
LEGISLATION AND JURISPRUDENCE;
MARKETING;
OPIOID-RELATED DISORDERS;
UNITED STATES;
DRUG INDUSTRY;
HUMANS;
KENTUCKY;
MARKETING;
NARCOTICS;
OPIOID-RELATED DISORDERS;
OXYCODONE;
|
EID: 84924928799
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.g6605 Document Type: Note |
Times cited : (7)
|
References (0)
|